Nanotechnology for Cancer Therapy
Coordonnateur : Amiji Mansoor M.
While simultaneous breakthroughs occurring in molecular biology and nanoscience/technology will ultimately revolutionize all of medicine, it is with our efforts to prevent, diagnose, and treat cancer that many of the most dramatic advances will occur. In support of this potential, the U.S. National Cancer Institute (NCI) established the Alliance for Nanotechnology in Cancer in 2004 and pledged $144.3 million in funding over the next five years.
Edited by one of the most dynamic pioneers in the field, Nanotechnology for Cancer Therapy focuses on those nanoscientific and nanotechnological strategies that are evolving as the most promising for the imaging and treatment of cancer. Among the various approaches considered, nanotechnology offers great possibilities for the targeted delivery of drugs and genes to tumor sites and the ultimate replacement of those chemotherapeutic agents so compromised by side effects.
Within this volume, the expertise of world-renowned academic and industrial researchers is brought together to provide a comprehensive treatise. Composed of 38 chapters, the book is divided into 7 sections that cover -
Date de parution : 11-2019
17.8x25.4 cm
Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).
Prix indicatif 74,82 €
Ajouter au panierDate de parution : 12-2006
Ouvrage de 814 p.
17.8x25.4 cm
Thèmes de Nanotechnology for Cancer Therapy :
Mots-clés :
PAMAM Dendrimer G5; Boron Neutron Capture Therapy; neoplasms therapy; Kb Cell; chemotherapy; PAMAM Dendrimer; antineoplastic agents; Prostate Specific Membrane Antigen; drug targeting; PSMA; Polymeric Micelles; Peg Chain; Polymeric Micellar Formulation; Cremophor EL; EPR Effect; Free DOX; Polymer Drug Conjugate; DNA Complex; Di-block Copolymer; Peg PLA Micelle; Paca Nanoparticles; TPA Cross-section; Peg Block; RGD Peptide; Cationic Liposomes; Cyclic RGD Peptide; Mri Contrast Agent; Metastatic Breast Cancer; Peg Pe Micelle